Evidence map›Paper›PMID 35296661›Full record

ArticleCell death & disease2022

Transcriptional control of retinal ganglion cell death after axonal injury.

Stephanie B Syc-Mazurek, Hongtian Stanley Yang, Olivia J Marola, Gareth R Howell, Richard T Libby

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. IL1A enhances TNF-induced retinal ganglion cell death.Frontiers in aging neuroscience · 2026
    Article
  4. Article
  5. Article
  6. A lead role for a "secondary" axonal injury response.Neural regeneration research · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stephanie B Syc-Mazurek *Department of Ophthalmology, University of Rochester Medical Center, Rochester, NY, USA.
Hongtian Stanley Yang *The Jackson Laboratory, Bar Harbor, ME, USA.
Olivia J MarolaDepartment of Ophthalmology, University of Rochester Medical Center, Rochester, NY, USA.ORCID 0000-0002-0078-6088
Gareth R HowellThe Jackson Laboratory, Bar Harbor, ME, USA. gareth.howell@jax.org.ORCID 0000-0003-0565-6474
Richard T LibbyDepartment of Ophthalmology, University of Rochester Medical Center, Rochester, NY, USA. richard_libby@urmc.rochester.edu.ORCID 0000-0003-2844-7632
University of Rochester Medical Center · USJackson Laboratory · US

Funding

The IU/JAX Alzheimer's Disease Precision Models Center: Rat F344U54AG054345 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI Paul Richard Territo · 2016 to 2026
$95.6M
TREAT AD Structural Biology CoreU54AG065187 · NIA · EMORY UNIVERSITY · PI ALLAN I LEVEY · 2019 to 2026
$69.7M
University of Rochester Mentoring Environment: Nurturing Training Opportunities in Research (UR-MENTOR)T32GM007356 · NIGMS · UNIVERSITY OF ROCHESTER · PI O'BANION, M. KERRY · 1985 to 2023
$15.1M
Cell Death Pathways in Glaucomatous NeurodegenerationR01EY018606 · NEI · UNIVERSITY OF ROCHESTER · PI JOHN, SIMON W, LIBBY, RICHARD T · 2008 to 2023
$5.8M
Cell specific roles of the endothelin system in glaucoma-relevant retinal ganglion cell deathR01EY027701 · NEI · UNIVERSITY OF ROCHESTER · PI HOWELL, GARETH R, LIBBY, RICHARD T · 2017 to 2021
$2.7M
Endothelin Signaling in Glaucomatous NeurodegenerationF31EY030739 · NEI · UNIVERSITY OF ROCHESTER · PI MAROLA, OLIVIA JOYCE · 2020 to 2021
$85k
NEI NIH HHS F31 EY030739NEI NIH HHS R01 EY018606NEI NIH HHS R01 EY027701NIA NIH HHS U54 AG054345NIA NIH HHS U54 AG065187NIGMS NIH HHS T32 GM007356
6 · The paper itself

Abstract

Injury to the axons of retinal ganglion cells (RGCs) is a key pathological event in glaucomatous neurodegeneration. The transcription factors JUN (the target of the c-Jun N-terminal kinases, JNKs) and DDIT3/CHOP (a mediator of the endoplasmic reticulum stress response) have been shown to control the majority of proapoptotic signaling after mechanical axonal injury in RGCs and in other models of neurodegeneration. The downstream transcriptional networks controlled by JUN and DDIT3, which are critical for RGC death, however, are not well defined. To determine these networks, RNA was isolated from the retinas of wild-type mice and mice deficient in Jun, Ddit3, and both Jun and Ddit3 three days after mechanical optic nerve crush injury (CONC). RNA-sequencing data analysis was performed and immunohistochemistry was used to validate potential transcriptional signaling changes after axonal injury. This study identified downstream transcriptional changes after injury including both neuronal survival and proinflammatory signaling that were attenuated to differing degrees by loss of Ddit3, Jun, and Ddit3/Jun. These data suggest proinflammatory signaling in the retina might be secondary to activation of pro-death pathways in RGCs after acute axonal injury. These results determine the downstream transcriptional networks important for apoptotic signaling which may be important for ordering and staging the pro-degenerative signals after mechanical axonal injury.

Indexed as

Optic Nerve InjuriesRetinal Ganglion CellsAnimalsAxonsDisease Models, AnimalMiceMice, Inbred C57BLRNARNA

Identifiers

PMID35296661
PMCPMC8927149
OpenAlexW4220946278

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.